Progela

ProGela is an Italian biotechnology company specializing in the development of advanced biomaterials for regenerative medicine and localized drug delivery. The company's core technology is a proprietary thermosensitive hydrogel platform that remains liquid at room temperature and transitions to a gel state at body temperature, allowing for minimally invasive administration. ProGela's primary focus is on oncology, specifically the local treatment of glioblastoma multiforme to prevent tumor recurrence after surgery. Additionally, the company explores applications in wound healing and the prevention of post-surgical adhesions. As a spin-off from the Politecnico di Milano, ProGela leverages deep expertise in polymer chemistry and bioengineering to address unmet medical needs.